KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas

Nucleic Acids Res. 1988 Aug 25;16(16):7773-82. doi: 10.1093/nar/16.16.7773.

Abstract

DNAs from human pancreatic adenocarcinomas were analyzed for the presence of mutations in codons 12, 13 and 61 of the NRAS, KRAS and HRAS gene. Formalin-fixed and paraffin-embedded tissue was used directly in an in vitro amplification reaction to expand the relevant RAS sequences. The mutations were detected by selective hybridization using mutation-specific synthetic oligonucleotides. In 28 of the 30 patients we found a mutation in codon 12 of the KRAS gene. This result confirms the findings of Almoguera et al. [Cell 53 (1988) 549-554] that KRAS mutations occur frequently in adenocarcinomas of the exocrine pancreas. The mutations are predominantly G-T transversions, in contrast to the KRAS mutations in colon tumors which are mainly G-A transitions. Furthermore, in a portion of the tumors the mutation appears to be homozygous.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / genetics*
  • Base Sequence
  • Codon / isolation & purification*
  • Colonic Neoplasms / genetics
  • Genes, ras* / drug effects
  • Humans
  • Lung Neoplasms / genetics
  • Molecular Sequence Data
  • Mutagens
  • Mutation*
  • Pancreatic Neoplasms / genetics*
  • RNA, Messenger / isolation & purification*

Substances

  • Codon
  • Mutagens
  • RNA, Messenger